HORIZON THERAPEUTICS

UPLIZNA is believed to work by lowering the levels of B cells in the body, which may reduce the overactive immune response found in individuals with NMOSD... During their first course of treatment 9.3% of people taking UPLIZNA experienced an infusion reaction, including headache, nausea, fever, sleepiness, shortness of breath, muscle aches and rash... UPLIZNA is the only treatment for NMOSD that is administered twice a year (after initial two start-up doses).

Also known as: Horizon, Horizon Therapeutics plc